Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter

Figures & data

Table 1 Clinical Characteristics of Patients with Psoriasis at Cipto Mangunkusumo Hospital, Jakarta (n = 36)

Characteristics	Number	Percentage	Mean/ Median	Standard Deviation	Minimum– Maximum
PASI			6.1		2–38.4
– Mild	18	50
– Moderate	10	27.8
– Severe	8	22.2
BSA (%)			7.5		2–93
AC (cm)			89	±10.23
– Normal	10	27.8
– Increased	26	72.2
BMI (kg/m^2)			26.36	±3.95
– Normal	16	44.4
– Obese	20	55.6
CAP (dB/m)			250.03	±45.64
– No NAFLD	8	22.2
– NAFLD	28	77.8

Abbreviations: AC, abdominal circumference; BSA, body surface area; CAP, controlled attenuation parameter; BMI, body mass index; PASI, psoriasis area and severity index; NAFLD, nonalcoholic fatty liver disease.

Figure 1 Correlation between PASI and CAP score among patients with psoriasis at Cipto Mangunkusumo Hospital, Jakarta (n = 36).

Abbreviations: CAP, controlled attenuation parameter; PASI, psoriasis area and severity index.

Figure 2 Correlation between BSA and CAP score among patients with psoriasis at Cipto Mangunkusumo Hospital, Jakarta (n = 36).

Abbreviations: BSA, body surface area; NAFLD, nonalcoholic fatty liver disease.